Company news
Assertio Holdings, Inc. news in 2022
Assertio Holdings, Inc.'s news releases, calls and decks from 2022, newest first.
Assertio Holdings, Inc. to Host Investor and Business Development Meetings January 9-11, 2023 in San Francisco
December 12, 2022
Assertio Increases Full-Year Net Product Sales Outlook to in Excess of $152 Million
December 4, 2022
Assertio Reports Third Quarter 2022 Financial Results
November 7, 2022
Assertio Holdings, Inc. to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
October 26, 2022
Assertio Holdings, Inc. Signs Exclusive License for Sympazan® (clobazam) Oral Film from Aquestive Therapeutics, Inc.
October 26, 2022
Assertio to Participate in October 2022 Investor Conferences
October 11, 2022
Assertio to Participate in the 2022 Lake Street BIG6 Conference
September 6, 2022
Assertio Announces Closing of $70 Million Convertible Senior Notes Offering
August 24, 2022
Assertio Prices $60 Million Convertible Senior Notes Offering to Refinance Existing 13% Senior Secured Notes Due 2024
August 21, 2022
Assertio Announces Proposed Convertible Senior Notes Offering to Refinance Existing 13% Senior Secured Notes Due 2024
August 21, 2022
Assertio Reports Second Quarter 2022 Financial Results
August 7, 2022
Assertio Holdings, Inc. To Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
July 24, 2022
Assertio Reports First Quarter 2022 Financial Results
May 8, 2022
Assertio Holdings, Inc. to Report First Quarter 2022 Financial Results After the Close of Markets on Monday, May 9, 2022
April 21, 2022
Assertio Holdings, Inc. Partners with BlinkRx to Support Healthcare Providers and Patients Utilizing Otrexup® (methotrexate) with a Unique Patient Access Solution
March 30, 2022
Assertio Reports Fourth Quarter and Full Year 2021 Financial Results
March 8, 2022
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results Before the Opening of Markets on Wednesday, March 9, 2022
March 1, 2022